These results confirm our previous analyses (Figs. 2 and 3), and indicate that more substantial changes at the genomic, transcriptomic, and proteomic levels between PT-IBTR pairs might directly stem from high proliferative activity and other features typical of ER-PgR negative cancers, though no further association was detected. This evidence concerns the gene ESR1 and cancer.